Share this postSuppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccinationmathewaldred.substack.comCopy linkFacebookEmailNoteOtherSuppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccinationAnother IgG4 paper.Mathew AldredOct 25, 2023∙ Paid8Share this postSuppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccinationmathewaldred.substack.comCopy linkFacebookEmailNoteOtherShareThis post is for paid subscribersAlready a paid subscriber? Sign in